Yahoo Web Search

Search results

1. Cassava Sciences, Inc.

   NasdaqCM: SAVA

   21.67

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.05 (-0.21%)

   At close: Tue. May 28, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Pre-Market Time

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	21.86
     High	22.00
     Low	21.18

   • Mkt Cap	1.04B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	21.72
     52 Wk. Low	12.32
     52 Wk. High	32.10

   More about SAVA

   Top stories

   • SAVA
     -0.21%

   Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Golden Cross

   Yahoo Finance · 6 days ago

   

   Related stocks

   • OCGN
     Ocugen, Inc.
     OCGN
     1.7100
     -2.29%
   • AVXL
     Anavex Life Sciences Corp.
     AVXL
     4.0700
     +1.75%
   • ANVS
     Annovis Bio, Inc.
     ANVS
     6.65
     -8.78%
   • VXRT
     Vaxart, Inc.
     VXRT
     0.8292
     -4.29%
   • BNGO
     Bionano Genomics, Inc.
     BNGO
     1.0300
     -3.74%

   More on Yahoo Finance

2. stockanalysis.com › stocks › savaCassava Sciences, Inc. (SAVA) Stock Price, Quote & News ...

   stockanalysis.com › stocks › sava

   • Cached

   5 days ago · SAVA is a biotechnology company developing drugs for neurodegenerative diseases. See its latest stock price, financials, statistics, forecast, dividends, profile, chart, news, and analysis on Stock Analysis.

3. markets.businessinsider.com › stocks › savaCassava Sciences Stock Price | SAVA Stock Quote, News, and ...

   markets.businessinsider.com › stocks › sava

   • Cached

   4 days ago · Cassava Sciences (SAVA) is a biotechnology company developing drugs for Alzheimer's disease. See the latest stock quote, news, historical prices, analyst ratings, and forecasts for SAVA on Markets Insider.

4. People also ask

   Is cassava Sciences (Sava) a good stock to buy?

   • After reaching an important support level, Cassava Sciences, Inc. (SAVA) could be a good stock pick from a technical perspective. SAVA recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.

   Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Gol…

   finance.yahoo.com/news/cassava-sciences-inc-sava-technical-135504402.html

   See all results for this question

   What does Sava stand for?

   • AUSTIN, Texas, March 25, 2024 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company focused on Alzheimer's disease, today announced the completion of another interim safet...

   Cassava Sciences, Inc. (SAVA) - Stock Analysis

   stockanalysis.com/stocks/sava/

   See all results for this question

   What are Sava share price targets?

   • Their SAVA share price targets range from $131.00 to $131.00. On average, they predict the company's stock price to reach $131.00 in the next twelve months. This suggests a possible upside of 469.3% from the stock's current price. View analysts price targets for SAVA or view top-rated stocks among Wall Street analysts.

   Cassava Sciences (SAVA) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/NASDAQ/SAVA/

   See all results for this question

   Is Sava (Sava) a good stock to buy?

   • Over the past four weeks, SAVA has gained 6.7%. The company currently sits at a #3 (Hold) on the Zacks Rank, also indicating that the stock could be poised for a breakout. The bullish case only gets stronger once investors take into account SAVA's positive earnings outlook for the current quarter.

   Cassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright After Key Gol…

   finance.yahoo.com/news/cassava-sciences-inc-sava-technical-135504402.html

   See all results for this question

5. www.marketbeat.com › stocks › NASDAQCassava Sciences (SAVA) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   4 days ago · Free SAVA Stock Alerts. $21.72. -0.09 (-0.41%) (As of 05/24/2024 ET) Compare. Share. Today's Range. $21.44. . $22.80. 50-Day Range. $19.64. . $26.11. 52-Week Range. $12.32. . $32.10. Volume. 638,387 shs. Average Volume. 831,581 shs. Market Capitalization. $1.04 billion. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $131.00. Stock Analysis.

   • 3.4/5
   • Phone: (512) 501-2444

   • Location: 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260, AUSTIN TX, 78731
   • Email: ir@paintrials.com

6. finance.yahoo.com › news › cassava-sciences-inc-savaCassava Sciences, Inc. (SAVA)'s Technical Outlook is Bright ...

   finance.yahoo.com › news › cassava-sciences-inc-sava

   • Cached

   6 days ago · Over the past four weeks, SAVA has gained 6.7%. The company currently sits at a #3 (Hold) on the Zacks Rank, also indicating that the stock could be poised for a breakout. The bullish case only...

7. simplywall.st › stocks › usCassava Sciences NasdaqCM:SAVA Stock Report - Simply Wall St

   simplywall.st › stocks › us

   • Cached

   May 17, 2024 · 1Y. -7.9% Updated. 27 May, 2024. Data. Company Financials +. 2 Analysts. SAVA Stock Overview. A clinical stage biotechnology company, develops drugs for neurodegenerative diseases. About the company. Rewards. Revenue is forecast to grow 32.59% per year. Risk Analysis. Makes less than USD$1m in revenue ($0)

8. www.marketbeat.com › stocks › NASDAQSAVA News Today | Why did Cassava Sciences stock go up today?

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   May 21, 2024 · May 17, 2024 | marketbeat.com. Cassava Sciences (NASDAQ:SAVA) Given New $131.00 Price Target at HC Wainwright. HC Wainwright raised their target price on Cassava Sciences from $124.00 to $131.00 and gave the stock a "buy" rating in a research report on Friday. May 16, 2024 | marketbeat.com.

9. www.marketscreener.com › quote › stockCompany Cassava Sciences, Inc. - MarketScreener.com

   www.marketscreener.com › quote › stock

   • Cached

   5 days ago · Cassava Sciences, Inc. is a biotechnology company focused on Alzheimer's disease. The Company's science is based on stabilizing, but not removing, a critical protein in the brain. The Company is focused on its product discovery and development efforts on disorders of the nervous system.